NEW YORK, NY / ACCESSWIRE / July 20, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
CytomX Therapeutics, Inc. (NASDAQ:CTMX)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=8041&wire=1
Lead Plaintiff Deadline: July 20, 2020
Class Period: May 17, 2018 - May 13, 2020
Allegations against CTMX include that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Pilgrim's Pride Corporation (NASDAQ:PPC)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/pilgrims-pride-corporation-loss-submission-form?prid=8041&wire=1
Lead Plaintiff Deadline: September 4, 2020
Class Period: February 9, 2017 - June 3, 2020
Allegations against PPC include that: (1) the Company and its executives had participated in an illegal antitrust conspiracy to fix prices and rig bids from at least as early as 2012 and continuing through at least early 2017; (2) the Company received competitive advantages, which persisted during the Class Period, from its anticompetitive conduct; and (3) as a result, Defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.
J2 Global, Inc. (NASDAQ:JCOM)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/j2-global-inc-loss-submission-form?prid=8041&wire=1
Lead Plaintiff Deadline: September 8, 2020
Class Period: October 5, 2015 - June 29, 2020
Allegations against JCOM include that: (1) J2 Global engaged in undisclosed related party transactions; (2) J2 Global used misleading accounting to hide requisite impairments and underperformance in acquisitions; (3) several so-called independent members of the Company' board of directors and audit committee were not disinterested; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com:
https://www.accesswire.com/598075/SHAREHOLDER-ALERT-CTMX-PPC-JCOM-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines
